SOLESENCE Sets August 28 Annual Meeting, Urges Shareholder Vote
Ticker: SLSN · Form: DEF 14A · Filed: Jul 30, 2025 · CIK: 883107
Sentiment: neutral
Topics: Proxy Statement, Annual Meeting, Corporate Governance, Shareholder Vote, Cosmetics Industry, SEC Filing, SLSN
Related Tickers: SLSN
TL;DR
**SOLESENCE's proxy filing is a procedural heads-up for the annual meeting; vote your shares by August 28, 2025, or the board decides for you.**
AI Summary
SOLESENCE, INC. (SLSN) filed a Definitive Proxy Statement (DEF 14A) on July 30, 2025, for its Annual Meeting of Stockholders scheduled for August 28, 2025, at 8:00 a.m. Central time at its Romeoville, Illinois headquarters. The filing indicates the company's primary business is 'PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS' (SIC 2844). While specific revenue and net income figures are not detailed in this particular DEF 14A, the document outlines the procedural aspects of the upcoming annual meeting, including voting instructions for shareholders via telephone, internet, or mail. Jess Jankowski, President and CEO, signed the letter to stockholders, emphasizing the importance of shareholder participation by August 28, 2025. The company, formerly known as NANOPHASE TECHNOLOGIES Corp, changed its name on February 8, 2016, and operates from 1319 Marquette Drive, Romeoville, Illinois. This filing primarily serves to inform shareholders about the meeting agenda and voting procedures, rather than providing a detailed financial update.
Why It Matters
This DEF 14A filing is crucial for SOLESENCE (SLSN) investors as it sets the stage for key corporate governance decisions at the August 28, 2025 Annual Meeting. Shareholder votes will determine board composition and other proposals, directly impacting the company's strategic direction in the competitive perfumes, cosmetics, and toilet preparations market. For employees, the outcomes could influence leadership stability and future business initiatives. Customers might see indirect effects through product development or market strategy shifts, while the broader market will watch for any signals regarding SLSN's operational health and competitive positioning against industry giants.
Risk Assessment
Risk Level: low — The risk level is low because this DEF 14A is a procedural filing for an annual meeting, not a disclosure of new financial results or significant operational changes. It primarily details voting instructions and the meeting date of August 28, 2025, at 8:00 a.m. Central time, with no immediate financial or operational risks highlighted.
Analyst Insight
Investors should review the full proxy statement for specific proposals and board recommendations, then cast their votes via telephone, internet, or mail before the August 28, 2025 deadline. Failure to vote means shares will be voted according to the Board of Directors' recommendations.
Key Numbers
- 2025-07-30 — Filing Date (Date the DEF 14A was filed with the SEC)
- 2025-08-28 — Annual Meeting Date (Date of SOLESENCE, INC.'s Annual Meeting of Stockholders)
- 8:00 a.m. — Meeting Time (Start time for the Annual Meeting of Stockholders)
- 2844 — SIC Code (Standard Industrial Classification for Perfumes, Cosmetics & Other Toilet Preparations)
- 001-42589 — SEC File Number (SOLESENCE, INC.'s SEC file number)
Key Players & Entities
- SOLESENCE, INC. (company) — Registrant for DEF 14A filing
- Jess Jankowski (person) — President and Chief Executive Officer of Solésence, Inc.
- SEC (regulator) — United States Securities and Exchange Commission
- NANOPHASE TECHNOLOGIES Corp (company) — Former name of Solésence, Inc. until February 8, 2016
- 1319 Marquette Drive, Romeoville, Illinois (company) — Corporate headquarters and location of the Annual Meeting
- August 28, 2025 (date) — Date of the Annual Meeting of Stockholders
- July 30, 2025 (date) — Filing date of the DEF 14A
- 8:00 a.m. Central time (time) — Start time of the Annual Meeting
FAQ
When is SOLESENCE, INC.'s Annual Meeting of Stockholders?
SOLESENCE, INC.'s Annual Meeting of Stockholders is scheduled for Thursday, August 28, 2025, at 8:00 a.m. Central time, as stated in the DEF 14A filing.
Where will the SOLESENCE Annual Meeting be held?
The SOLESENCE Annual Meeting will be held at the company's corporate headquarters, located at 1319 Marquette Drive, Romeoville, Illinois, on August 28, 2025.
Who is the President and CEO of SOLESENCE, INC.?
Jess Jankowski is the President and Chief Executive Officer of SOLESENCE, INC., and he signed the letter to stockholders included in the DEF 14A filing.
What is the deadline for SOLESENCE shareholders to vote?
SOLESENCE shareholders must submit their votes prior to August 28, 2025, for them to be included in the official voting at the Annual Meeting.
What happens if a SOLESENCE shareholder returns a proxy card without specifying choices?
If a SOLESENCE shareholder signs and returns their proxy card without specifying choices, their shares will be voted in accordance with the recommendations of the Board of Directors, as outlined in the Proxy Statement.
What is SOLESENCE, INC.'s primary business according to its SIC code?
SOLESENCE, INC.'s primary business, according to its Standard Industrial Classification (SIC) code 2844, is 'PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS'.
When did SOLESENCE, INC. change its name from NANOPHASE TECHNOLOGIES Corp?
SOLESENCE, INC. changed its name from NANOPHASE TECHNOLOGIES Corp on February 8, 2016, according to the company data in the DEF 14A filing.
What is the purpose of a DEF 14A filing for SOLESENCE?
The DEF 14A filing for SOLESENCE serves as a definitive proxy statement, informing stockholders about the upcoming Annual Meeting, the matters to be acted upon, and providing instructions on how to vote their shares.
How can SOLESENCE stockholders vote their shares?
SOLESENCE stockholders can vote their shares via telephone, over the Internet, or by signing, dating, and returning the proxy card in the postage-paid envelope provided, as detailed in the DEF 14A.
What is the SEC file number for SOLESENCE, INC.?
The SEC file number for SOLESENCE, INC. is 001-42589, as indicated in the DEF 14A filing.
Industry Context
SOLESENCE, INC. operates within the Perfumes, Cosmetics & Other Toilet Preparations industry (SIC 2844). This sector is characterized by brand loyalty, innovation in product development, and significant marketing efforts. Competition often comes from both large, established players and smaller niche brands, with trends influenced by consumer preferences for natural ingredients, sustainability, and personalized products.
Regulatory Implications
As a publicly traded company, SOLESENCE, INC. is subject to SEC regulations governing proxy solicitations and shareholder communications. Compliance with disclosure requirements, such as those outlined in this DEF 14A, is crucial to maintain transparency and avoid potential penalties. The company must ensure accurate and timely dissemination of information to shareholders.
What Investors Should Do
- Vote your shares for the Annual Meeting of Stockholders by August 28, 2025, to ensure your voice is heard.
- Review the DEF 14A filing for details on the matters to be voted upon at the annual meeting.
- Consider attending the Annual Meeting on August 28, 2025, at 8:00 a.m. Central time at the Romeoville, Illinois headquarters.
Key Dates
- 2025-07-30: Filing of Definitive Proxy Statement (DEF 14A) — Provides shareholders with information regarding the upcoming annual meeting and voting procedures.
- 2025-08-14: Mailing of 2025 Proxy Statement and proxy card — Informs shareholders about the meeting agenda and how to vote their shares.
- 2025-08-28: Annual Meeting of Stockholders — The date for shareholders to vote on company matters and for the company to conduct its annual business.
Glossary
- DEF 14A
- A Definitive Proxy Statement filed with the SEC by a public company. It contains information about the annual meeting of shareholders, including matters to be voted on, director nominees, and executive compensation. (This document is the primary filing for SOLESENCE, INC.'s annual meeting, outlining the procedural aspects and shareholder voting.)
- Proxy Card
- A document that allows a shareholder to authorize another person (usually a company representative) to vote their shares on their behalf at a shareholder meeting. (Shareholders are instructed to sign and return the proxy card if they cannot attend the meeting, ensuring their vote is counted.)
- SIC Code
- Standard Industrial Classification code, a four-digit number used to classify industries. SIC 2844 is for Perfumes, Cosmetics & Other Toilet Preparations. (Identifies SOLESENCE, INC.'s primary business sector, providing context for its operations and market.)
Year-Over-Year Comparison
This DEF 14A filing focuses on the procedural aspects of the 2025 Annual Meeting of Stockholders and does not provide comparative financial data against the previous year's filing. Key metrics such as revenue, net income, and margins are not detailed within this document. The primary purpose is to inform shareholders about the meeting date, voting methods, and the importance of participation.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on July 30, 2025 by Jess Jankowski regarding SOLESENCE, INC. (SLSN).